BWXT agrees to sell medical business to Nordic Capital in deal valued up to $800 million

PUBT · 1d ago
BWXT agrees to sell medical business to Nordic Capital in deal valued up to $800 million
  • BWX Technologies agreed to sell its medical business to Nordic Capital in a transaction valued at up to USD 800 million.
  • The deal includes BWXT Medical and Kinectrics’ stable medical isotopes business.
  • BWXT will retain a minority stake and continue providing isotope and radiochemical expertise under the agreement.
  • Proceeds will shift resources toward BWXT’s nuclear national security and commercial nuclear power markets.
  • Closing is expected by the end of 2026, subject to customary regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BWX Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608031605BIZWIRE_USPR_____20260803_BW155801) on August 03, 2026, and is solely responsible for the information contained therein.